NOMAD Power Solutions (NMAD) investor relations material

Executive summary

• Completed strategic transformation with the acquisition of NOMAD Transportable Power Systems, expanding into AI energy infrastructure and battery energy storage systems (BESS).

• Renamed to Nomad Power Solutions, Inc. and began trading under a new ticker symbol on July 6, 2026.

• Continued focus on clinical-stage biopharmaceutical and proton therapy operations, with LB-100 as the lead product candidate.

Financial highlights

• Net loss for Q2 2026 was $2.34 million, compared to $0.78 million in Q2 2025.

• Net loss for the six months ended June 30, 2026 was $4.33 million, up from $1.49 million for the same period in 2025.

• General and administrative costs rose 220% year-over-year to $2.29 million for Q2 2026, and 196% to $3.94 million for the six-month period.

• Research and development costs were $62,250 for Q2 2026, nearly flat year-over-year; for the six months, R&D costs increased 160% to $395,626.

• Cash balance as of June 30, 2026 was $12.67 million, with working capital of $17.8 million.

Outlook and guidance

• Management does not expect sustainable operating revenue for several years and anticipates continued negative cash flows as development programs advance.

• Additional capital will be required to fund ongoing clinical trials and recommission the LIGHT system equipment.

• Substantial doubt exists regarding the ability to continue as a going concern for at least 12 months beyond the report date.